GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6
针对复发或难治性多发性骨髓瘤的 GRP78 靶向免疫疗法——单克隆免疫球蛋白 M 抗体 PAT-SM6 的 1 期试验结果
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2014.117945
Rasche, Leo; Duell, Johannes; Castro, Inês C; Dubljevic, Valentina; Chatterjee, Manik; Knop, Stefan; Hensel, Frank; Rosenwald, Andreas; Einsele, Hermann; Topp, Max S; Brändlein, Stephanie
